COMMODORE CAPITAL LP 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-27 4:05 pm Sale |
2023-04-24 | 13G | Ambrx Biopharma Inc. AMAM |
COMMODORE CAPITAL LP | 31,181,983 8.100% |
-4,518,017 (-12.66%) |
Filing |
| 2023-03-03 4:10 pm Purchase |
2023-02-23 | 13G | Ambrx Biopharma Inc. AMAM |
COMMODORE CAPITAL LP | 35,700,000 13.200% |
9,450,000 (+36.00%) |
Filing |
| 2023-03-03 4:05 pm Purchase |
2023-02-21 | 13G | Ambrx Biopharma Inc. AMAM |
COMMODORE CAPITAL LP | 26,250,000 9.700% |
26,250,000 (New Position) |
Filing |